[1]Li PK, Chow KM, Van de Luijtgaarden MW, et al.Changes in the worldwide epidemiology of peritoneal dialysis[J].Nat Rev Nephrol, 2017, 13(2):90-103
[2]Brimble KS, Walker M, Margetts PJ, et al.Meta-analysis: peritoneal membrane transport,mortality,and technique failure in peritoneal dialysis[J].J Am Soc Nephrol, 2006, 17(9):2591-2598
[3]Sawai A, Ito Y, Mizuno M, et al.Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients[J]. Nephrol Dial Transplant, 2010, 26(7):2322-2332
[4]Rumpsfeld M, Mcdonald SP, Johnson DW.Higher Peritoneal Transport Status Is Associated with Higher Mortality and Technique Failure in the Australian and New Zealand Peritoneal Dialysis Patient Populations[J].J Am Soc Nephrol, 2006, 17(1):271-278
[5]Taimeh Z, Loughran J, Birks EJ, et al.Vascular endothelial growth factor in heart failure[J].Nat Rev Cardiol, 2013, 10(9):519-530
[6]Hiroshi K, Yasuhiko I, Ting S, et al.Roles of the TGF-β–VEGF-C pathway in fibrosis-related lymphangiogenesis[J].Int J Mol Sci, 2018, 19(9):2487--
[7]Teng L, Chang M, Liu S, et al.Peritoneal microvascular endothelial function and the microinflammatory state are associated with baseline peritoneal transport characteristics in uremic patients[J].Int Urol Nephrol, 2015, 47(1):191-199
[8]Rodrigues AS, Martins M, Korevaar JC, et al.Evaluation of Peritoneal Transport and Membrane Status in Peritoneal Dialysis: Focus on Incident Fast Transporters[J].Am J Nephrol, 2007, 27(1):84-91
[9]Hao N, Chiou TT, Wu CH, et al.Longitudinal Changes of PAI-1, MMP-2, and VEGF in Peritoneal Effluents and Their Associations with Peritoneal Small-Solute Transfer Rate in New Peritoneal Dialysis Patients[J]. Biomed Res Int, 2019, 2019:1-7
[10]Pecoits-Filho R, Araújo MR, Lindholm B, et al.Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate[J].Nephrol Dial Transplant, 2002, 17(8):1480-1486
[11]Szeto CC, Chow KM, Poon P, et al.Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients[J].Kidney Int, 2004, 65(5):1947-1955
[12]Kariya T, Nishimura H, Mizuno M, et al.TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis[J].Am J Physiol Renal Physiol, 2018, 314(2):F167-F180
[13]Kinashi H, Ito Y, Mizuno M, et al.TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis[J].J Am Soc Nephrol, 2013, 24(10):1627-1642
[14]Oh KH, Jung JY, Yoon MO, et al.Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients[J].Nephrol Dial Transplant, 2010, 25(5):1639-1646
[15]Yang X, Zhang H, Hang Y, et al.Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study[J].Am J Nephrol, 2014, 39(6):459-465
[16]Yang X, Yan H, Jiang N, et al.IL-6 Trans-signaling Drives a STAT3-dependent Pathway That Leads to Structural Alterations of Peritoneal Membrane[J].Am J Physiol Renal Physiol, 2019, 318(2):F338-F353
[17]Mizutani M, Ito Y, Mizuno M, et al.Connective tissue growth factor (CTGFCCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate[J].Am J Physiol Renal Physiol, 2010, 67(3):F721-F733
[18]Toda N, Mori K, Kasahara M, et al.Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation[J].Nephrol Dial Transplant, 2018, 33(6):943-953
[19]Kinashi H, Toda N, Sun T, et al.Connective tissue growth factor is correlated with peritoneal lymphangiogenesis[J].Sci Rep, 2019, 9(1):12175--
[20]Shi Y, Yan H, Yuan J, et al.Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients[J].BMC Nephrol, 2018, 19(1):119--
[21]Xiao J, Guo J, Liu XX, et al.Soluble Tie2 fusion protein decreases peritoneal angiogenesis in uremic rats[J].Mol Med Rep, 2013, 8(1):267-271
[22]Yuan J, Fang W, Lin A, et al.Angiopoietin-2Tie2 signaling involved in TNF-α induced peritoneal angiogenesis[J].Int J Artif Organs, 2012, 35(9):655-662
[23]Kiribayashi K, Masaki T, Naito T, et al.Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK12 and p38 MAPK[J].Kidney Int, 2005, 67(3):1126-1135
[24]陈琪婕，方炜，严豪，等.腹透患者透出液癌抗原水平变化与患者预后的关系[J].上海交通大学学报医学版, 2016, 36(003):393-398
[25]Rodrigues A, Martins M, Santos MJ, et al.Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport[J].Adv Perit Dial, 2004, 20:8-12
[26]Igarashi Y, Morishita Y, Yoshizawa H, et al.The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis[J].Ren Fail, 2017, 39(1):392-399
[27]Christ-Crain M, Fenske W.Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis[J].Nat Rev Endocrinol, 2016, 12(3):168-176
[28]Fijakowski M, Safranow K, Lindholm B, et al.Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients[J].Int Urol Nephrol, 2019, 51(9):1667-1673
[29]Ossorio M, Bajo MA, Peso GD, et al.Sustained low peritoneal effluent CCL18 levels are associated with preservation of peritoneal membrane function in peritoneal dialysis[J].PLoS One, 2017, 12(4):e0175835--
[30]Faria B, Gaya da Costa M, Lima C, et al.Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function[J].J Nephrol, 2021, 34(3):801-810
